GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (NYSE:BHC) » Definitions » E10

BHC (Bausch Health) E10 : $-2.67 (As of Sep. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Bausch Health E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bausch Health's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.67 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -8.70% per year. During the past 5 years, the average E10 Growth Rate was -13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bausch Health was 37.40% per year. The lowest was -59.30% per year. And the median was -7.70% per year.

As of today (2024-12-13), Bausch Health's current stock price is $7.75. Bausch Health's E10 for the quarter that ended in Sep. 2024 was $-2.67. Bausch Health's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Bausch Health was 669.00. The lowest was 79.39. And the median was 336.43.


Bausch Health E10 Historical Data

The historical data trend for Bausch Health's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health E10 Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.94 -2.06 -2.47 -2.48 -2.53

Bausch Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.41 -2.53 -2.51 -2.54 -2.67

Competitive Comparison of Bausch Health's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Shiller PE Ratio falls into.



Bausch Health E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bausch Health's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.23/127.2847*127.2847
=-0.230

Current CPI (Sep. 2024) = 127.2847.

Bausch Health Quarterly Data

per share eps CPI Adj_EPS
201412 1.560 98.367 2.019
201503 0.280 99.789 0.357
201506 -0.150 100.500 -0.190
201509 0.140 100.421 0.177
201512 -0.980 99.947 -1.248
201603 -1.080 101.054 -1.360
201606 -0.880 102.002 -1.098
201609 -3.490 101.765 -4.365
201612 -1.470 101.449 -1.844
201703 1.790 102.634 2.220
201706 -0.110 103.029 -0.136
201709 3.690 103.345 4.545
201712 1.450 103.345 1.786
201803 -7.360 105.004 -8.922
201806 -2.490 105.557 -3.003
201809 -1.000 105.636 -1.205
201812 -0.983 105.399 -1.187
201903 -0.150 106.979 -0.178
201906 -0.490 107.690 -0.579
201909 -0.140 107.611 -0.166
201912 -4.299 107.769 -5.077
202003 -0.430 107.927 -0.507
202006 -0.920 108.401 -1.080
202009 0.200 108.164 0.235
202012 -0.430 108.559 -0.504
202103 -1.710 110.298 -1.973
202106 -1.660 111.720 -1.891
202109 0.520 112.905 0.586
202112 0.190 113.774 0.213
202203 -0.190 117.646 -0.206
202206 -0.400 120.806 -0.421
202209 1.100 120.648 1.161
202212 -1.130 120.964 -1.189
202303 -0.550 122.702 -0.571
202306 0.070 124.203 0.072
202309 -1.030 125.230 -1.047
202312 -0.110 125.072 -0.112
202403 -0.170 126.258 -0.171
202406 0.030 127.522 0.030
202409 -0.230 127.285 -0.230

Add all the adjusted EPS together and divide 10 will get our e10.


Bausch Health  (NYSE:BHC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Bausch Health was 669.00. The lowest was 79.39. And the median was 336.43.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bausch Health E10 Related Terms

Thank you for viewing the detailed overview of Bausch Health's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Carson officer: EVP, General Counsel 400 SOMERSET CORPORATE BLVD, BRIDGEWATER NJ 08807
John S Barresi officer: SVP, Controller & CAO 727 FIFTH AVENUE, NEW YORK NY 10022
Richard Mulligan director C/O ICAHN CAPITAL LP, 767 FIFTH AVENUE, SUITE 4700, NEW YORK NY 10153
Tom George Vadaketh officer: EVP, Chief Financial Officer 1727 JOCKEYS WAY, YARDLEY PA 19067
Robert Spurr director, officer: U.S. President-Pharma Business C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Joseph F Gordon officer: Pres&Co-Head Bausch&Lomb/Int'l C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Frederick Munsch officer: SVP, Controller and CAO C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Christina Ackermann officer: EVP AND GENERAL COUNSEL C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Sam Eldessouky officer: EVP & Chief Financial Officer C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Steven D Miller director 16690 COLLINS AVENUE, PH, SUNNY ISLE BEACH FL 33160
Von Eschenbach Andrew C. director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
De Schutter Richard U director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Brett Icahn director C/O ICAHN ENTERPRISES L.P., 16690 COLLINS AVE., PH, SUNNY ISLES FL 33160
William D. Humphries officer: EVP, COMPANY GROUP CHAIRMAN C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA 19044
Valueact Capital Master Fund, L.p. director, other: See remarks ONE LETTERMAN DRIVE, BUILDING D, 4TH FLOOR, SAN FRANCISCO CA 94129